Role of Prostaglandin (PG) and Peroxisome Proliferator-Activated Gamma (PPAR amp;#947; ) in Pulmonary Fibrosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6387 |5|1|3-5

ISSN： 1573-398x

Source： Current Respiratory Medicine Reviews, Vol.5, Iss.1, 2009-02, pp. : 3-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins Therapy may Change a Course of Lung Fibrosis and Pulmonary Hypertension: A New Indication for Therapy or Just amp;#x201C;Statinomaniaamp;#x201D;?

By  

Current Respiratory Medicine Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 21-27

Bentham Science Publishers

Access to resources Recommend Favorite

Idiopathic Pulmonary Fibrosis: An EU Patient Perspective Survey

By  

Current Respiratory Medicine Reviews, Vol. 9, Iss. 2, 2013-07 ,pp. : 112-119

Bentham Science Publishers

Access to resources Recommend Favorite

Lung Remodeling in Interstitial Pneumonia: A New Molecular Target of Pulmonary Fibrosis

By  

Current Respiratory Medicine Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 93-101

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial from Editor-in-Chief [amp;#x2018;Chronic Obstructive Pulmonary Disease: Economical Burden and Quality of Life in 2008amp;#x201D;]

By  

Current Respiratory Medicine Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 233-233

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial from Guest Editor (Thematic Issue: Is Pleuroparenchymal Fibroelastosis the Same Disorder as Pulmonary Upper Lobe Fibrosis?)

By  

Current Respiratory Medicine Reviews, Vol. 9, Iss. 4, 2014-01 ,pp. : 227-228

Bentham Science Publishers

Access to resources Recommend Favorite